| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Do | 6 Analysts Assess LifeStance Health Gr: What You Need To Know | 1 | Benzinga.com | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| Do | KeyBanc raises Lifestance Health stock price target on productivity | 1 | Investing.com | ||
| Do | Lifestance outlines $1.615B-$1.655B 2026 revenue target while advancing AI, EHR initiatives and $100M buyback | 3 | Seeking Alpha | ||
| Mi | LifeStance stockholders plan 25M share offering | 1 | Investing.com | ||
| Mi | LifeStance: Aktionäre planen Verkauf von 25 Millionen Aktien | 1 | Investing.com Deutsch | ||
| Mi | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| Mi | LifeStance Health Group, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| Mi | LifeStance Health Group, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| Mi | LifeStance Health Q4 2025 slides: revenue beats, EBITDA soars 49% | 1 | Investing.com | ||
| Mi | Earnings Summary: LifeStance Health Gr Q4 | 1 | Benzinga.com | ||
| Mi | LifeStance Health Group reports Q4 results; introduces FY26 outlook | 1 | Seeking Alpha | ||
| Mi | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | 266 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 24.02. | Lifestance Health vor Quartalszahlen: Weg zur Profitabilität im Fokus | 1 | Investing.com Deutsch | ||
| 02.02. | LifeStance Health Gr Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) | 2 | Benzinga.com | ||
| 22.01. | Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes | 1 | Insider Monkey | ||
| 08.11.25 | LifeStance (LFST) Soars 30% on Q3 Earnings Blowout | 1 | Insider Monkey | ||
| 06.11.25 | Lifestance anticipates mid-teens revenue growth for 2026 while raising adjusted EBITDA guidance amid record productivity gains | 6 | Seeking Alpha | ||
| 06.11.25 | LifeStance Health Group, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11.25 | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | 553 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,210 | -5,06 % | Märkte am Morgen: Warner Bros-Übernahme, PayPal, AMC Entertainment, Fresenius, Jost Werke | Der DAX ist nach dem schwachen Handel am Montag auch gestern nicht in die Gänge gekommen. Letzten Endes ging der DAX 0,02 Prozent tiefer bei 24.986 Punkten aus dem Handel. Heute könnte er die Rückkehr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,510 | -0,83 % | DAX fester, Bitcoin tiefer: FMC, MTU, IBM, Telekom, Infineon, Airbus, SAP, Gerresheimer im ... | Der DAX hat am Montag Verluste einstecken müssen. Aus dem Handel ging er mit einem Minus von 1,1 Prozent bei 24.991,97 Punkten. Der Start in den Dienstag dürfte hingegen etwas freundlicher sein. Der... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,070 | -3,14 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,360 | -1,71 % | Carl Zeiss Meditec-Aktie: Zehnjahrestief erreicht - was Anleger jetzt wissen müssen | ||
| TELADOC HEALTH | 4,454 | +1,00 % | Teladoc Health Q4 Loss Narrows | WASHINGTON (dpa-AFX) - Teladoc Health, Inc. (TDOC) on Wednesday reported a fourth-quarter net loss of $25.1 million, or $0.14 per share, compared to $48.4 million or $0.28 per share last year.Fourth-quarter... ► Artikel lesen | |
| ROKU | 81,21 | -3,22 % | Jim Cramer on Roku: "I Think It's a Very Smart, Very Smart Thing to Buy" | ||
| DEXCOM | 62,90 | -0,33 % | Kevin Sayer returns from leave of absence to chair Dexcom board | ||
| INMODE | 11,385 | -2,40 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| PETMED EXPRESS | 2,360 | +0,51 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| ORGANON | 6,010 | -2,37 % | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| TANDEM DIABETES | 21,220 | -1,62 % | TANDEM DIABETES CARE INC - 8-K, Current Report | ||
| INSULET | 208,30 | -0,76 % | Insulet Corp. Q4 Sales Increase | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) revealed a profit for fourth quarter of $101.6 millionThe company's earnings totaled $101.6 million, or $1.44 per share. This compares with $102.9... ► Artikel lesen | |
| MOLINA HEALTHCARE | 124,85 | -4,22 % | Chief Accounting Officer At Molina Healthcare Buys $400K of Stock | ||
| QUIDELORTHO | 19,100 | -1,55 % | QuidelOrtho Corporation: QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio | Agreement adds new analyzer platforms and expands assay menu across key international marketsSAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 1,691 | -3,37 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 10-K, Annual Report |